Abstract Previous studies have demonstrated that all-trans retinoic acid (RA) increases collagen production and decreases matrix metalloproteinase (MMP) activity in organ-cultured human skin. Decreased MMP activity is associated with up-regulation of tissue inhibitor of metalloproteinase-1 (TIMP-1). These changes are accompanied by a hyperplastic response in the epidermis. Here we show that a synthetic picolinic ester-substituted retinoid (designated as MDI 301) has comparable eVects to those of RA in regard to these activities. What makes these Wndings of interest is that RA also stimulates elaboration of several pro-inXammatory cytokines and up-regulates leukocyte adhesion molecules in organ-cultured skin. MDI 301 does not induce such changes or is much less active. In a past study we showed that while RA was irritating to the skin of topically treated hairless mice, MDI 301 was essentially non-irritating under the same conditions [Varani et al. (2003) Arch. Dermatol Res 295:255-262]. Taken in conjunction with the Wndings from the past study, the present data suggest that MDI 301 will be similar to RA in capacity to repair damaged skin, but will be eVective under conditions that are not irritating. These Wndings, thus, suggest that retinoid eYcacy and clinically relevant irritancy are not inextricably linked. Potential for eYcacy under conditions in which irritation is not observed is a strong rationale for further development of MDI 301 as a skin-repair agent.
Introduction
Topical application of all-trans retinoic acid (RA) improves the appearance of skin damaged as a consequence of chronic exposure to ultraviolet radiation from the sun (photoaging) [17, 33] . Retinoid use also improves the appearance of chronologically aged skin [16] . In both photoaging and natural aging, there is a loss of intact collagen and an increase in fragmented collagen in the skin [10, 26, 32] . RA treatment reverses the increased expression of connective tissue-degrading matrix metalloproteinases (MMPs) that are responsible for collagen degradation in the skin [7, 8] and concomitantly stimulates new collagen synthesis [13, 32] . These cellular events lead to changes in connective tissue structure that are visible at the histological level and, presumably, underlie the improved appearance. This has been convincingly demonstrated in both clinical studies and experimental animal models [16] [17] [18] [19] 33] . Given the ability of RA to reduce collagen damage and induce new collagen synthesis, it is not surprising that topical retinoid use not only improves the appearance of damaged skin but also results in better function. SpeciWcally, a number of past studies have demonstrated that RA-pretreatment improves healing of wounds that subsequently occur in skin that has been damaged as a result of aging/photoaging or as a consequence of diabetes or chronic corticosteroid use [2, 20, 25, 34, 36] .
A consequence of topical retinoid use is skin irritation. Irritated skin is characterized by redness, dryness and Xaking at the treated site. At the histological level, one sees a perivascular accumulation of mononuclear cells, with neutrophils and monocyes scattered throughout the dermis and occasional micro-abscesses in the dermis or epidermis [12] . All-trans retinol (vitamin A), the parent compound of RA, tends to be less irritating than RA in most cases, but even with this agent, signiWcant irritation is observed in many individuals [15] . Likewise, skin irritation is also a complication with synthetic agents currently on the market [3] . Irritation is a major cause of non-compliance among retinoid users. In addition, excessive irritation may counteract the beneWcial eVects of topical use.
It has been assumed in the past that retinoid eYcacy and retinoid irritation could not be separated. Recent studies, however, cast doubt on this. We demonstrated in a recent study that an ester-substituted derivative of 9-cis RA (termed MDI 301) was as eYcacious as RA or 9-cis RA in stimulating epidermal hyperplasia and dermal thickening when applied topically to the skin of hairless mice [28] . Unlike RA, the synthetic agent appeared to be completely non-irritating to the rodent skin following topical use. Although hairless mice are commonly used as model for retinoid responses in skin, whether or not MDI 301 will be as eVective as RA in repairing aged or photoaged human skin can only be established with human skin, itself. As a way to begin addressing this issue, MDI 301 and RA were compared for eVects on human skin cells (dermal Wbroblasts and epidermal keratinocytes) in monolayer culture and for eVects on human skin in organ culture. The data presented here demonstrate that in both monolayer and organ culture models, MDI 301 was able to stimulate events that underlie skin repair. Of interest, MDI-301 did not up-regulate pro-inXammatory cytokines including interleukin-1 (IL-1 ), IL-6, IL-8, or macrophage chemotactic peptide-1 (MCP-1) while these cytokines were induced by RA. Concomitantly, MDI 301 was less eVective than RA in inducing expression of intercellular adhesion molecule-1 (ICAM-1) and E-Selectin in the microvasculature of organ-cultured skin.
Materials and methods

Retinoids
MDI 301 is a 9-cis RA derivative in which the terminal carboxylic acid group has been replaced by a picolinic ester. MDI 301 was synthesized as described in the original patent (US Patent 5,837,728; Molecular Design International; Memphis, TN) and our previous report [28] . RA was purchased from Sigma Chemical Company (St. Louis, MO). Both retinoids were stored at ¡80°C protected from light. For use in cell culture and organ culture, the two retinoids were prepared in DMSO at 20 mg/ml, aliquoted and frozen at ¡80°C protected from light. The DMSO stocks were stable for at least 1 year. At the time of use, the retinoids were diluted directly in culture medium at a Wnal working solution of no greater than 5 g/ml. At this concentration, the Wnal amount of DMSO in the medium was 0.025 l/ml. At this level, DMSO had no detectable eVects on cell function.
Human skin organ culture Replicate 2-mm punch biopsies were obtained from hip skin of volunteers less than 70 years of age. The participation of human subjects in this study was approved by the University of Michigan Institutional Review Board and all subjects provided written informed consent prior to their inclusion in the study. The punch biopsies were incubated in wells of a 24 well dish (one tissue piece per 250 l of culture medium). Culture medium consisted of Keratinocyte Basal Medium (KBM) (Cambrex Biologicals, Walkersville, MD). KBM is a modiWcation of MCDB-153 medium. For our purposes, it was supplemented with calcium chloride to a Wnal Ca 2+ concentration of 1.4mM. One well was left as control while the others were treated with RA or MDI 301 (0.5-1 g/ml). Fresh culture medium was provided at 2-day intervals. Organ culture-conditioned medium was saved for assessment of type-I procollagen, MMPs (MMP-2 and -9) and tissue inhibitor of metalloproteinases-1 (TIMP-1) as described below. The same culture Xuid was also analyzed for IL-1 , IL-6, IL-8 and MCP-1 as described below. At the end of the incubation period (normally at day-8), organ-cultured tissue was Wxed in 10% buVered formalin and embedded in paraYn. Fivem thick sections were cut and stained with hematoxylin and eosin. Representative sections of each biopsy were selected for histological evaluation and photographed. Epidermal thickness measurements were made from these tissue sections. In certain experiments, tissue was frozen in Optimal Cutting Temperature (OCT) medium and used for immunohistology. Human skin in organ culture has been extensively used in the past to help understand how RA aVects skin structure and function. The organ culture protocol used here is virtually identical to that described in a past report [30] .
MMP production
Substrate embedded Enzymography (zymography) was used in these studies to assess levels of latent and active MMP-2 and MMP-9 in organ culture and cell culture Xuids. As described previously [21] , SDS-PAGE gels were prepared with the incorporation of gelatin (1 mg/ml) at the time of casting. After electrophoresis and overnight incubation, zones of hydrolysis were identiWed and quantiWed. Values for latent and active MMP-2 and MMP-9 bands were obtained.
Type-I procollagen
Culture Xuids were assayed for type-I procollagen by enzyme-linked immunosorbant assay (ELISA) (Pan Vera Corp., Madison, WS) as described previously [21] . Type-I procollagen has the terminal peptide sequences that are present at synthesis and, therefore, is a measure of ongoing collagen synthesis.
TIMP-1 production
Culture Xuids were assayed for TIMP-1 by ELISA using a commercially available assay kit (R&D Systems, Mpls. MN) [21] .
Cytokines
Levels of IL-1 , IL-6, IL-8 and MCP-1 were quantiWed. Individual ELISA kits were used for IL-6, IL-8 and MCP-1 while IL-1 was quantiWed as part of a multiplex assay (BioSource International Inc., Camarillo, CA).
Immunohistology
Organ-cultured tissue was Wxed in OCT medium after two days of incubation. The frozen tissue was sectioned and stained for expression of ICAM-1 or E-Selectin. The antibody to ICAM-1 was a mouse monoclonal IgG1 antibody (HA58) from BD-Pharmingen (San Jose, CA). The antibody to E-Selectin was also a mouse monoclonal IgG1 antibody (clone 7A9) obtained from the American Type Culture Collection (ATCC). The sections were stained by the immunoperoxidase method and the reaction product was visualized using diaminobenzadine as the chromogenic substrate. Immunostained sections were examined by light microscopy.
Human epidermal keratinocytes and human dermal Wbroblasts in monolayer culture
Normal human epidermal keratinocytes and normal human dermal Wbroblasts were isolated from 2-mm punch biopsies of skin as described previously [30] . Primary and early passage keratinocytes were maintained in Keratinocyte Growth Medium (KGM) (Cambrex Inc.). KGM consists of the same basal medium as KBM but is further supplemented with a mixture of growth factors including 0.1 ng/ml EGF, 0.5 g/ml insulin, and 2% bovine pituitary extract. In addition to using low-passage keratinocytes, we also used the HaCat line of immortalized human epidermal keratinocytes in some experiments [4] . The immortalized keratinocytes were handled exactly as low-passage keratinocytes.
Fibroblasts were obtained from the same tissue and grown in monolayer culture using Dulbecco's ModiWed Minimal Essential Medium supplemented with nonessential amino acids and 10% fetal bovine serum (DMEM-FBS). Both keratinocytes and Wbroblasts were maintained at 37°C in an atmosphere of 95% air and 5% CO 2 . Cells were subcultured by exposure to trypsin/ethylenediamine tetraacetic acid (EDTA) and used at passage 2-3.
Keratinocyte adhesion assay
Keratinocytes adhesion was assessed as described previously [29] . BrieXy, cells were plated in wells of a 24-well dish at 5 £ 10 4 cells per well in growth medium and treated with RA or MDI 301. At the end of the incubation period, cells were exposed to a solution of 0.05% trypsin/0.02% EDTA and incubated for 15 min. At the end of the incubation period, non-attached cells from each well were harvested and counted. Fresh trypsin/EDTA solution was added and the cells re-incubated until all had detached. Cells recovered in the Wnal incubation were also counted. The percentage of cells detached at the intermediate time-point was determined from these values.
Fibroblast survival assay
Fibroblast survival was assessed as described previously [31] . BrieXy, cells were seeded at 5 £ 10 4 cells per well in DMEM-FBS (24-well plate) and allowed to attach overnight. Following this, cells were washed and put into assay buVer (KBM). KBM consists of the same basal medium as KGM but is not supplemented with growth factors. Cells were treated with diVerent concentrations of MDI 301 (or RA), and cell numbers were assessed three days later. For counting, cells were released from the substrate with trypsin/EDTA and enumerated using a particle counter (Coulter Electronics, Hialeah, FL).
Results
Histological features of retinoid-treated human skin in organ culture: comparison of RA and MDI 301
In the Wrst series of experiments, replicate two-mmpunch biopsies were obtained from 10 diVerent individuals. The tissue pieces were incubated in organ culture for 8 days under control conditions or treated with RA or MDI 301 (0.5-1.0 g/ml) as described in the Materials and Methods section. At the end of the incubation period, histological features were assessed. Consistent with past reports, tissue incubated in control medium (i.e., serum-free, growth factor-free KBM supplemented with Ca 2+ to a Wnal concentration of 1.4 mM) maintained normal histological features (Fig. 1a) . In contrast, skin exposed to either RA or MDI 301 demonstrated epidermal hyperplasia. There was no signiWcant diVerence between the two retinoids. This can be seen from the histological images presented in Fig. 1b (RA) and Fig. 1c (MDI 301 ) and from the quantitative assessment shown in the lower part of Fig. 1 . Hyperplasia was accompanied by features of abnormal diVerentiation consisting of a loss of granular cells, areas of incomplete keratinization and, in extreme cases, ancanthosis in the upper epidermis. These features were, perhaps, more prominent in cultures of RAtreated skin than in skin exposed to MDI 301 (Fig. 1b,   c ), but were, in fact, present in a majority of specimens treated with either agent.
In addition to examining organ-cultured human skin for changes in epidermal structure, eVects of retinoid treatment on dermal features were also examined. Neither agent induced observable histological changes in the connective tissue structure over the 8-day period (Fig. 1) . This is not surprising since previous studies have shown that several weeks to months are required before improvement in collagen structure is observed with topical application of RA to human skin [16, 33] .
MMP-2, MMP-9 and TIMP-1 in organ cultures of retinoid-treated human skin: comparison of RA and MDI-301
Organ culture Xuids were harvested on day 4 and assayed for the presence of latent and active forms of both MMP-2 and MMP-9. Consistent with our past Wndings [21] , approximately equal amounts of active and latent MMP-9 were present in control organ culture Xuids. Also consistent, the relative amount of active MMP-9 was reduced in organ culture Xuid from RA-treated skin relative to that of control cultures. As seen in Fig. 2a , treatment of skin organ cultures with MDI 301 produced the same change in overall ratio of latent to active MMP-9 as did RA. In contrast, neither retinoid signiWcantly aVected the levels of active or Fig. 1 Upper panel Histological features of untreated, RA-treated and MDI 301-treated human skin in organ culture. Tissue from normal (hip) skin was maintained in organ culture for 8 days under serum-free, growth factor-free conditions alone or in the presence of 0.5 g/ml RA or 0.5 g/ml MDI 301. At the end of the incubation period, the tissue was Wxed in 10% buVered formalin and examined at the light microscopy level after sectioning and staining with hematoxylin and eosin. a Control; b RA-treated; c MDI 301-treated (X320). Lower panel Epidermal thickness measurements. Values are means and standard errors based on organ cultures from ten individuals with the average from control tissue set to 1.0. Statistical signiWcance of the diVerence between untreated and retinoid-treated samples was determined by ANO-VA followed by paired-group comparisons. * indicates P < 0.05 relative to control skin latent MMP-2 (Fig. 2a) . The same serum-free, growth factor-free culture Xuids were examined for TIMP-1 levels by ELISA. As indicated in Fig. 2b , there was a signiWcant increase in levels of the MMP inhibitor in culture Xuid from tissue treated with either retinoid in comparison with levels in culture Xuid from control tissue.
Collagen production in retinoid-treated human skin in organ culture: comparison of RA and MDI 301 Serum-free, growth factor-free culture Xuids obtained from organ cultures after 2 days of incubation were examined for type-I procollagen by ELISA. As indicated in Fig. 3 , there was a signiWcant increase in levels of type-I procollagen in culture Xuid from tissue treated with either retinoid in comparison with levels in control culture Xuid. No diVerence between the two retinoids was observed.
EVects of RA and MDI 301 on cytokine elaboration and leukocyte adhesion molecule expression in organ-cultured skin Serum-free, growth factor-free culture Xuids were obtained from organ cultures after 2 days of incubation and examined for pro-inXammatory cytokines (IL-1 , IL-6, IL-8 and MCP-1) by ELISA. As indicated in Fig. 4 , increased levels of all four cytokines were observed in culture Xuid from tissue treated with RA in comparison with levels in control culture Xuid. Tissue treated with MDI 301 did not show increased expression of these pro-inXammatory cytokines.
Organ cultures were incubated for 2 days under control conditions or in the presence of either RA or MDI dard errors based on organ cultures from nine volunteers. Statistical signiWcance of the diVerences among the three groups was determined by ANOVA followed by paired-group comparisons. *Indicates P < 0.05 relative to control skin. b TIMP-1. Organ culture Xuid was collected on day-4 from untreated and RA-treated and MDI-301-treated skin and assayed for TIMP-1 by ELISA. Values shown are means and standard errors, based on organ cultures from nine individuals. Statistical signiWcance of the diVerence between untreated and retinoid-treated samples was determined by ANOVA followed by paired-group comparisons. * indicates P < 0.05 relative to control skin Fig. 3 Type-1 procollagen production in untreated, RA-treated and MDI 301-treated human skin in organ culture. Organ culture Xuid was collected on day-2 and assayed for Type-1 procollagen by ELISA. Values shown are means and standard errors, based on organ cultures from nine individuals. Statistical signiWcance of the diVerence between untreated and retinoid-treated samples was determined by ANOVA followed by paired-group comparisons. * indicates P < 0.05 relative to control skin 301 (1 g/ml). At the end of the incubation period, the tissue was frozen in OCT and stained with antibody to ICAM-1. Staining was stronger in the RA-treated skin than in skin exposed to MDI-301 (Fig. 5 ). DiVerences were especially evident in the lower dermis (Fig. 5) . When sections from the same tissues were stained with an antibody to another leukocyte adhesion molecule (E-Selectin), similar results were obtained. That is, staining was more intense in RA-treated skin than in the other groups (not shown).
EVects of RA and MDI 301 on keratinocyte adhesive function in monolayer culture Epidermal keratinocytes were established in monolayer culture and exposed to RA or MDI 301 over a range of concentrations. After 2 days, retinoid-treated keratinocytes were examined for alterations in cellsubstrate adhesive function. Both retinoids signiWcantly increased keratinocyte sensitivity to trypsin/ EDTA-mediated release from the substratum (Fig. 6) . Concentrations that decreased cell-substrate adhesiveness spanned the range of concentrations that have previously been shown to stimulate keratinocyte proliferation (0.01-0.5 g/ml) as well as concentrations that are growth-inhibitory [28] . The dose-response curves for the two agents were virtually identical.
EVects of RA and MDI 301 on Wbroblast survival Next, RA and MDI 301 were examined for eVects on Wbroblast survival under low-ca 2+ conditions in monolayer culture. Consistent with past results, human dermal Wbroblasts lysed when cultured in low-Ca 2+   Fig. 4 Cytokine production in retinoid-treated skin. Organ culture Xuid was collected on day-2 and assayed for each of the cytokines by ELISA. Values obtained with control culture Xuid from each individual was set to 1.0 and the values obtained in retinoidtreated skin normalized to the control value. Values shown are means and standard errors, based on organ cultures from six individuals (0.15 mM), serum-free, growth factor-free culture medium (31) . Also consistent with our past Wndings, RA prevented cell death in a dose-dependent fashion in the low-Ca 2+ medium (Fig. 7) . MDI-301, likewise, prevented Wbroblast death under low-Ca 2+ conditions. However, in comparison with RA, eVective concentrations were higher (Fig. 7) . With RA, the ED 50 for prevention of Wbroblast death in the serum-free, growth factor-free, low-Ca 2+ environment was 0.3 g/ml while with MDI-301, the corresponding ED 50 was 2.0 g/ml. 
Discussion
RA and the other biologically active derivatives of vitamin A (all-trans retinol) have hormone-like activities in the skin. Where the skin has become hyperplastic (for example, in psoriasis and in certain malignancies), retinoids eVectively suppress proliferation [6, 9] . On the other hand, where skin cell proliferation has slowed (for example, in aged skin), retinoid stimulate growth and result in epidermal thickening [32] . Retinoid stimulatory eVects also extend to the dermis, where suppression of the major collagen-degrading enzymes [7, 8] and stimulation of procollagen synthesis [13, 18, 19] improve appearance [16, 17, 33] and improve the healing of wounds that subsequently occur [2, 20, 25, 34] . In spite of the beneWcial eVects, the capacity of RA to irritate the skin makes it less than desirable for many users. At one time it was believed that retinoid eYcacy and retinoid irritation could not be separated. This may not be entirely correct. Others have shown that vitamin A mediates events similar to RA but is less irritating in human skin [15] . It has also been shown that by carefully controlling the dosage, irritation can be mitigated under conditions in which beneWcial activities remain [12] . In a past study we showed that a synthetic, ester-substituted retinoid (i.e., MDI 301) was similar to RA in its ability to induce epidermal hyperplasia in hairless mice and to induce a thickening of the collagen band immediately beneath the epidermis [28] . These changes in skin structure were seen in spite of the fact that unlike RA, there was essentially no irritation in the skin of the MDI 301-treated animals. Although hairless rodents are commonly used as a model for retinoid responses in skin, rodent skin is signiWcantly diVerent from human skin, and it is important to establish beneWcial eVects in human skin.
Here we show that human skin in organ culture responds to MDI 301 with similar responses as observed with RA. The two retinoids induced a comparable degree of hyperplasia in the epidermis. At supra-optimal concentrations, both retinoids induced abnormalities in the upper epidermis (hyperkeratosis, acantholysis and partial separation of the diVerentiating cells from the basal cells). Along with the reduced epidermal cohesiveness observed in whole skin, treatment of keratinocytes with either RA or MDI 301 in monolayer culture resulted in decreased cell-substrate adhesion. The two retinoids were also comparable in stimulating type-I procollagen synthesis and inhibiting MMP function. MMP reduction was accompanied by increased production of TIMP-1 with both agents.
Based on these data, we suggest that MDI 301 will ultimately prove to be an eVective skin-repair agent.
In addition to examining events related to eYcacy, we also compared the two retinoids for eVects on cellular responses that may contribute to irritation. MDI-301 was clearly less active than RA in inducing production of pro-inXammatory cytokines and in up-regulating leukocyte adhesion molecules (events closely tied to skin inXammation). What accounts for these diVerences, however, is unknown. Retinoid irritation is a complex and not completely understood problem. It has been suggested that irritation is, in some manner, connected to epidermal hyperplasia. Rapidly proliferating keratinocytes elaborate large amounts of pro-inXammatory cytokines [22, 23] . In addition to inducing hyperplasia, retinoid treatment also alters the pattern of diVerentiation in the epidermis and reduces barrier function [5, 11, 14] . The loss of barrier function rather than hyper-proliferation per se may be directly responsible for promoting pro-inXammatory events [35] . Our data do not contradict these suggestions. On the other hand, our Wndings strongly imply that hyperplasia and irritation are not inextricably linked. Even changes in epidermal barrier function (to the extent that the observations made here-altered diVerentiation, separation of upper epidermal layers from the basal layer and decreased adhesiveness in vitro-reXect alterations in the epidermal barrier) appear not to be directly responsible for irritation. In all these regards, the eVects of RA and MDI 301 were comparable. Yet RA stimulated the production of pro-inXammatory cytokines under conditions in which MDI-301 did not.
Although there was no observable diVerence in the epidermal response to the two retinoids (either in organ culture or with keratinocytes in monolayer culture) that might suggest a basis for the diVerence in irritancy, the two retinoids were signiWcantly diVerent in their capacity to prevent Wbroblast lysis under low-Ca 2+ conditions (ED 50 = 0.3 g/ml with RA as compared with 2.0 g/ml with MDI 301). Whether this diVerence is related, in any way, to the diVerence in irritancy is not known. Of interest in this regard, it has been demonstrated previously that certain detergents such as sodium lauryl sulfate also preserve Wbroblast viability under low-Ca 2+ conditions [27] . Since retinoid has a detergent-like structure (polar head group connected to a hydrophobic, fatty acid tail) and have been shown to function in a detergent-like manner [24] , perhaps irritation is a function of the detergent property. If this turns out to be the case, then it may be that MDI 301, with its ester substitution for the free acid group, is inherently less detergent-like than RA.
Another possibility is that the lower capacity of the ester-substituted retinoid to induce irritation reXects altered penetrability. In a past study comparing RA and MDI-301 for anti-cancer activity, it was noted that both retinoids induced epidermal hyperplasia in nude mice following intraperitoneal injection [1] . While there was no signiWcant skin irritation in either group of mice, mice injected with either RA or MDI 301 developed a comparable degree of splenomegaly with enlarged germinal centers (indicative of a systemic inXammatory response).
Regardless of the underlying mechanism, it is clear from our recent study that MDI 301 is inherently less irritating that RA when used topically in hairless rodents [28] . The Wndings presented here demonstrate that MDI-301 is comparable to RA in its ability to induce events that underlie repair of damaged skin in human skin, but unlike RA, does not induce elaboration of pro-inXammatory cytokines or up-regulate expression of leukocyte adhesion molecules in the skin. Our studies, therefore, (1) suggest that repair eYcacy and irritation are not inextricably linked; (2) provide insight into possible mechanisms of irritation; and (3) provide a rationale for further development of MDI 301 as a skin-repair agent.
